TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Biomentek AS
Closing information (x1000 EUR)
| Closing information | 2022/12 | 2021/12 | 2020/12 |
| Turnover |
3,283
|
2,303
|
1,506 |
| Financial expenses |
6
|
14
|
10 |
| Earnings before taxes |
209
|
109
|
28 |
| Total assets |
1,026
|
743
|
576 |
| Current assets |
818
|
624
|
449 |
| Current liabilities |
541
|
391
|
318 |
| Equity capital |
429
|
325
|
226 |
| - share capital |
67
|
71
|
67 |
Financial ratios
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Solvency |
41.8%
|
43.7%
|
39.2% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
6.4%
|
4.7%
|
1.9% |
| Return on assets (ROA) |
21.0%
|
16.6%
|
6.6% |
| Current ratio |
151.2%
|
159.6%
|
141.2% |
| Return on equity (ROE) |
48.7%
|
33.5%
|
12.4% |
| Change turnover |
1,101
|
715
|
156 |
| Change turnover % |
50%
|
45%
|
12% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.